Hospital Outcomes of Patients Receiving Catheter Ablation of Atrial Fibrillation, Left Atrial Appendage Closure, or Both

Overview

Journal J Interv Card Electrophysiol

Publisher Springer

Date 2022 Sep 17

PMID 36114936

Authors

Ramez Morcos

Haider Al Taii

Muni Rubens

Anshul Saxena

Venkataraghavan Ramamoorthy

Mohamed Hamed

Amr F Barakat

Nitin Kulkarni

Houman Khalili

Santiago Garcia

Michael Megaly

Emir Veledar

Stavros Stavrakis

Affiliations

Soon will be listed here.

Abstract

Background: Catheter ablation (CA) and left atrial appendage closure (LAAC) require transseptal access; combining both in a single procedure may have advantages. However, the safety of this approach has not been extensively studied. The objective of this study was to compare in hospital outcomes among patients receiving CA, LAAC, and combination of both treatments on the same day.

Methods: We conducted a retrospective cohort analysis of the National Inpatient Sample database. The primary outcome was the presence of major adverse cardiovascular and cerebrovascular events (MACCE) during index hospitalization. Secondary outcomes included stroke, pericardial effusion, pericardiocentesis, and bleeding.

Results: A total of 69,285 hospitalizations with AF were included in the analysis, of which 71.7% received LAAC, 27.8% received CA, and 0.5% received combination of both treatments on the same day. MACEE (OR, 1.63; 95% CI, 0.39-6.70), stroke (OR, 2.98; 95% CI, 0.55-16.01), pericardial effusion (OR, 0.33; 95% CI, 0.07-1.41), pericardiocentesis (OR, 1.00; 95% CI, 0.25-3.86), and bleeding (OR, 3.25; 95% CI, 0.87-12.07) did not differ significantly between CA and combination treatment. Similarly, MACCE (OR, 1.11; 95% CI, 0.28-4.41), stroke (OR, 1.03; 95% CI, 0.24-4.35), pericardial effusion (OR, 0.45; 95% CI, 0.11-1.90), pericardiocentesis (OR, 0.63; 95% CI, 0.14-2.83), and bleeding (OR, 2.04; 95% CI, 0.65-6.39) did not differ significantly between LAAC and combination treatment.

Conclusions: The combined approach is infrequently used in clinical practice (< 1%). However, major life-threatening adverse events did not differ between CA and LAAC when performed in isolation or combined in a single procedural stage on the same day.

References

Go A, Hylek E, Phillips K, Chang Y, Henault L, Selby J . Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285(18):2370-5. DOI: 10.1001/jama.285.18.2370. View

Camm A, Kirchhof P, Lip G, Schotten U, Savelieva I, Ernst S . Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010; 12(10):1360-420. DOI: 10.1093/europace/euq350. View

Noseworthy P, Kapa S, Haas L, Van Houten H, Deshmuk A, Mulpuru S . Trends and predictors of readmission after catheter ablation for atrial fibrillation, 2009-2013. Am Heart J. 2015; 170(3):483-9. DOI: 10.1016/j.ahj.2015.05.018. View

Shah R, Freeman J, Shilane D, Wang P, Go A, Hlatky M . Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2012; 59(2):143-9. PMC: 5340189. DOI: 10.1016/j.jacc.2011.08.068. View

Wintgens L, Klaver M, Swaans M, Alipour A, Balt J, van Dijk V . Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices. Europace. 2018; 21(3):428-433. DOI: 10.1093/europace/euy237. View

Gloekler S, Saw J, Koskinas K, Kleinecke C, Jung W, Nietlispach F . Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation. Int J Cardiol. 2017; 249:234-246. DOI: 10.1016/j.ijcard.2017.08.049. View

Liu J, Xia Y, Zhang H, Li X, Zhang S, Fang P . Left atrial appendage closure after cryoballoon ablation in patients with atrial fibrillation. Herz. 2020; 46(Suppl 1):82-88. DOI: 10.1007/s00059-019-04880-4. View

Boersma L, Schmidt B, Betts T, Sievert H, Tamburino C, Teiger E . Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J. 2016; 37(31):2465-74. PMC: 4996118. DOI: 10.1093/eurheartj/ehv730. View

Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P . Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation. J Am Coll Cardiol. 2020; 75(25):3122-3135. DOI: 10.1016/j.jacc.2020.04.067. View

10.

Black-Maier E, Piccini J, Granger C . Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2019; 30(12):2968-2976. DOI: 10.1111/jce.14182. View

11.

Price M, Reddy V, Valderrabano M, Halperin J, Gibson D, Gordon N . Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience. JACC Cardiovasc Interv. 2015; 8(15):1925-1932. DOI: 10.1016/j.jcin.2015.08.035. View

12.

Reddy V, Doshi S, Kar S, Gibson D, Price M, Huber K . 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol. 2017; 70(24):2964-2975. DOI: 10.1016/j.jacc.2017.10.021. View

13.

Ren Z, Zhang J, Zhu M, Zhao D, Li S, Yang H . Cryoablation Combined with Left Atrial Appendage Closure: A Safe and Effective Procedure for Paroxysmal Atrial Fibrillation Patients. Cardiol Res Pract. 2020; 2020:6573296. PMC: 7171640. DOI: 10.1155/2020/6573296. View

14.

Packer D, Mark D, Robb R, Monahan K, Bahnson T, Poole J . Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019; 321(13):1261-1274. PMC: 6450284. DOI: 10.1001/jama.2019.0693. View

15.

Swaans M, Post M, Rensing B, Boersma L . Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study. J Am Heart Assoc. 2013; 1(5):e002212. PMC: 3541623. DOI: 10.1161/JAHA.112.002212. View

16.

Fassini G, Conti S, Moltrasio M, Maltagliati A, Tundo F, Riva S . Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation. Europace. 2016; 18(11):1705-1710. DOI: 10.1093/europace/euw007. View

18.

Ren Z, Zhang J, Wang S, Jia P, Li X, Zhang J . Two-Year Outcome From Combining Cryoballoon Ablation and Left Atrial Appendage Closure: CLACBAC Study. Front Cardiovasc Med. 2021; 7:610537. PMC: 7829213. DOI: 10.3389/fcvm.2020.610537. View

19.

Calvo N, Salterain N, Arguedas H, Macias A, Esteban A, Garcia de Yebenes M . Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation. Europace. 2015; 17(10):1533-40. DOI: 10.1093/europace/euv070. View

20.

Du X, Chu H, Ye P, He B, Xu H, Jiang S . Combination of left atrial appendage closure and catheter ablation in a single procedure for patients with atrial fibrillation: Multicenter experience. J Formos Med Assoc. 2018; 118(5):891-897. DOI: 10.1016/j.jfma.2018.10.006. View

21.

Brinjikji W, Rabinstein A, Kallmes D, Cloft H . Patient outcomes with endovascular embolectomy therapy for acute ischemic stroke: a study of the national inpatient sample: 2006 to 2008. Stroke. 2011; 42(6):1648-52. DOI: 10.1161/STROKEAHA.110.607952. View